Paul Rothman

Insider Reports History

Entity
Individual
Location
6 Meadow Road, Baltimore, MD
Signature
/s/ Sandra D. van der Vaart, Attorney-in-Fact for Paul Rothman
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Paul Rothman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Merck & Co., Inc. Director Phantom Stock 28.2K $3.54M $125.54 May 31, 2024 Direct
LABCORP HOLDINGS INC. Director Restricted Stock Unit 944 $199K $210.84 Jun 6, 2024 Direct
LABCORP HOLDINGS INC. Director Common Stock 717 $151K $210.84 Jun 6, 2024 Direct
Merck & Co., Inc. Director Common Stock 100 $12.8K $127.51 May 31, 2024 Direct

Insider Reports Filed by Paul Rothman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LH LABCORP HOLDINGS INC. Jun 6, 2024 2 $0 4 Jun 10, 2024 Director
MRK Merck & Co., Inc. May 31, 2024 1 $220K 4 Jun 4, 2024 Director
LH LABORATORY CORP OF AMERICA HOLDINGS Feb 6, 2024 1 $0 4 Feb 8, 2024 Director
LH LABORATORY CORP OF AMERICA HOLDINGS Jun 6, 2023 1 $0 4 Jun 8, 2023 Director
LH LABORATORY CORP OF AMERICA HOLDINGS Jun 6, 2023 0 $0 3 Jun 7, 2023 Director
MRK Merck & Co., Inc. May 26, 2023 1 $220K 4 May 31, 2023 Director
MRK Merck & Co., Inc. May 27, 2022 1 $220K 4 Jun 1, 2022 Director
MRK Merck & Co., Inc. May 28, 2021 1 $200K 4 Jun 2, 2021 Director